Delivery Order SPE2DB22D1017-SPE2DB24FF7DG

Award Date 5/3/24
Potential Completion Date 5/6/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,977.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical supplies to DLA facilities...
This federal contract award, valued at $1,086.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The delivery order contract is for the supply of TRULICITY 4.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) is a $2,031.96 firm fixed-price delivery order for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has an ultimate completion date of April 30, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive...
This federal contract award is a delivery order valued at $7,748.16 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a prescription pharmaceutical product. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
This federal contract award, valued at $1,741.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a delivery order for the supply of TRULICITY 4.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. Amerisourcebergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $1,741.68, is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract is a Firm Fixed Price Delivery Order issued under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of...
This federal contract award, valued at $3,346.96, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a prescription medication, to DLA facilities supporting the Department of Defense worldwide. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award, valued at $1,001.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division. The contract provides for the delivery of the pharmaceutical product TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. This is a firm fixed-price delivery order contract with a performance period ending on July 23, 2024. The contract does not have a set-aside designation. As a major pharmaceutical distributor, Amerisourcebergen has been awarded numerous...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,428.06 firm-fixed-price delivery order is for TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of January 23, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $7,568.64, was issued by the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the delivery of the pharmaceutical product TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FF7DG
    Delivery Order

This federal contract award, valued at $1,741.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Firm Fixed Price Delivery Order for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product.

Amerisourcebergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The current contract award does not have a set-aside designation.

Generated 8/2/24, 9:47 AM